BCM
GILD icon

Bridgeway Capital Management’s Gilead Sciences GILD Stock Holding History

Bridgeway Capital Management’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-603,600
Closed -$37.8M – 1362
2018
Q4 		$37.8M Sell
603,600
-183,200
-23% -$12.8M 0.5% 75
2018
Q3 		$60.7M Sell
786,800
-297,750
-27% -$22.5M 0.59% 51
2018
Q2 		$76.8M Buy
1,084,550
+20,175
+2% +$1.42M 0.78% 18
2018
Q1 		$80.2M Sell
1,064,375
-20,600
-2% -$1.64M 0.86% 13
2017
Q4 		$77.7M Buy
1,084,975
+334,710
+45% +$25.4M 0.84% 15
2017
Q3 		$60.8M Buy
750,265
+434,310
+137% +$33.2M 0.69% 35
2017
Q2 		$22.4M Sell
315,955
-10,825
-3% -$720K 0.27% 104
2017
Q1 		$22.2M Buy
326,780
+6,870
+2% +$483K 0.27% 104
2016
Q4 		$22.9M Buy
319,910
+42,790
+15% +$3.18M 0.3% 99
2016
Q3 		$21.9M Buy
277,120
+9,950
+4% +$808K 0.33% 95
2016
Q2 		$22.3M Sell
267,170
-14,010
-5% -$1.24M 0.35% 99
2016
Q1 		$25.8M Buy
281,180
+935
+0.3% +$84.3K 0.43% 75
2015
Q4 		$28.4M Buy
280,245
+740
+0.3% +$77K 0.53% 36
2015
Q3 		$27.4M Buy
279,505
+6,040
+2% +$671K 0.57% 21
2015
Q2 		$32M Sell
273,465
-14,260
-5% -$1.56M 0.63% 17
2015
Q1 		$28.2M Buy
287,725
+25,400
+10% +$2.58M 0.58% 19
2014
Q4 		$24.7M Buy
262,325
+29,980
+13% +$3.1M 0.56% 25
2014
Q3 		$24.7M Sell
232,345
-10,110
-4% -$990K 0.62% 18
2014
Q2 		$20.1M Sell
242,455
-2,675
-1% -$208K 0.53% 30
2014
Q1 		$17.4M Buy
245,130
+15,930
+7% +$1.25M 0.5% 36
2013
Q4 		$17.2M Buy
229,200
+177,500
+343% +$12.4M 0.52% 36
2013
Q3 		$3.25M Sell
51,700
-400
-0.8% -$23.9K 0.11% 189
2013
Q2 		$2.67M Buy
+52,100
New +$2.72M 0.11% 232

Other funds holding GILD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Bridgeway Capital Management's GILD Position: Q1 2019 in Review

Bridgeway Capital Management sold out of Gilead Sciences (GILD) in Q1 2019, closing a stake of 603,600 shares — an estimated $37.8M sold.

Bridgeway Capital Management first reported a position in GILD in Q2 2013 and held it in 23 quarters. The position peaked at $80.2M in Q1 2018. 1,491 funds tracked by Wall St. Rank hold GILD as of Q1 2019.

  • Bridgeway Capital Management reported no remaining Gilead Sciences position as of Q1 2019 after selling out during the quarter.
  • Bridgeway Capital Management sold 603,600 Gilead Sciences shares in Q1 2019, an estimated $37.8M.
  • Bridgeway Capital Management first reported a position in Gilead Sciences in Q2 2013 and held it in 23 quarters.
  • Bridgeway Capital Management's Gilead Sciences position peaked at $80.2M in Q1 2018.
  • 1,491 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2019.

Based on Bridgeway Capital Management's 13F filing for Q1 2019, filed 15 May 2019.